News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Nova Mentis Receives Controlled Substances Export Approval From The U.S. DEA For The Company's Proprietary Psilocybin Drug NM 1001
Nova Mentis Life Science
Lobe Sciences Announces Share Consolidation
Lobe Sciences
Blackhawk Appoints Justin Hanka as Chairman of The Board
MindBio Therapeutics
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Stability Test Under a Health Canada Approved cGMP Laboratory
Red Light Holland
Psychedelic Headlines | June 3rd
Cybin Inc.
Clearmind Medicine
Optimi Health
PsyBio Therapeutics
Awakn Life Sciences
Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study
Nirvana Life Sciences
Braxia Scientific Presents Positive Preliminary Findings from Phase II Randomized, Multi-Dose Clinical Trial of Psilocybin-Assisted Therapy for Treatment Resistant Depression
Braxia Scientific Corp.
PharmAla Biotech Supports Decision to Decriminalize Possession of MDMA in British Columbia
Pharmala Biotech Holdings
Clearmind Medicine and SciSparc Collaboration Yields Another Patent Application for Cocaine Addiction Treatment
Clearmind Medicine
Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder
Awakn Life Sciences
Psyence Group Corporate Update
Psyence Group
PsyBio Therapeutics Initiates Commercial Biosynthetic Based Process Development for Psycho-Targeted and Psychoactive Compounds
PsyBio Therapeutics
Novamind Announces New Patient Financing Options
Novamind Inc.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.